Associated Papers
Population-based analysis of POT1 variants in a cutaneous melanoma case-control cohort.
Simonin-Wilmer I et al.
Journal of Medical Genetics, 2023
36539277 (PubMed )
Supplement: jmg-2022-108776supp006.xlsx › Supplementary_Table_2_newID
POT1 mutations cause differential effects on telomere length leading to opposing disease phenotypes.
Zade NH et al.
Journal of Cellular Physiology, 2023
Characterization of clonal immunoglobulin heavy V-D-J gene rearrangements in Chinese patients with chronic lymphocytic leukemia: Clinical features and molecular profiles.
Deng X et al.
Frontiers in Oncology, 2023
36874132 (PubMed )
Supplement: Table_1.xlsx › Sheet1
IGH Translocations in Chinese Patients With Chronic Lymphocytic Leukemia: Clinicopathologic Characteristics and Genetic Profile.
Li Q et al.
Frontiers in Oncology, 2022
35720006 (PubMed )
Supplement: Table_2.xlsx › Sheet1
A rare missense variant in protection of telomeres 1 (POT1) predisposes to a range of haematological malignancies.
Nathan V et al.
British Journal of Haematology, 2021
Constitutional variants in POT1, TERF2IP, and ACD genes in patients with melanoma in the Polish population.
Malińska K et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ecp), 2020
Germline Variants in the POT1-Gene in High-Risk Melanoma Patients in Austria.
Müller C et al.
G3 (bethesda, Md.), 2018
Select a paper to view details